Yingchi Zhang

Dr. Yingchi Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JYJiyuan Yan
Jiyuan Yan
CLChaoxu Liu
Chaoxu Liu
CTChang Tu
Chang Tu
RZRuizhuo Zhang
Ruizhuo Zhang
XTXiangyu Tang
Xiangyu Tang
GSGaohong Sheng
Gaohong Sheng
Background: Cartilage damage is a common medical issue in clinical practice. Complete cartilage repair remains a significant challenge owing to the inferior quality of regenerative tissue. Safe and non-invasive magnetic therapy combined with tissue engineering to repair cartilage may be a promising breakthrough. Methods: In this study, a composite scaffold made of Hydroxyapatite-Collagen type-I (HAC) and PLGA-PEG-PLGA thermogel was produced to match the cartilage and subchondral layers in osteochondral defects, respectively. Bone marrow mesenchymal stem cells (BMSC) encapsulated in the thermogel were stimulated by an electromagnetic field (EMF). Effect of EMF on the proliferation and chondrogenic differentiation potential was evaluated in vitro. 4 mm femoral condyle defect was constructed in rabbits. The scaffolds loaded with BMSCs were implanted into the defects with or without EMF treatment. Effects of the combination treatment of the EMF and composite scaffold on rabbit osteochondral defect was detected in vivo. Results: In vitro experiments showed that EMF could promote proliferation and chondrogenic differentiation of BMSCs partly by activating the PI3K/AKT/mTOR and Wnt1/LRP6/β-catenin signaling pathway. In vivo results further confirmed that the scaffold with EMF enhances the repair of osteochondral defects in rabbits, and, in particular, cartilage repair. Conclusion: Hydrogel-Hydroxyapatite-Monomeric Collagen type-I scaffold with low-frequency EMF treatment has the potential to enhance osteochondral repair.

30 July 2022 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
YZYingchi Zhang
Yingchi Zhang
RLRui Lu
Rui Lu
HXHuang XiaoJian
Huang XiaoJian
EYEnzhi Yin
Enzhi Yin
YYYong Yang
Yong Yang
XYXuefeng Yuan
Xuefeng Yuan
Osteoarthritis (OA) is a rheumatic disease and its pathogenesis involves the dysregulation of noncoding RNAs. Therefore, the regulatory mechanism of circular RNA MELK (circMELK) was specified in this work. OA human cartilage tissue was collected, and circMELK, miR‐497‐5p, and myeloid differentiation factor 88 (MYD88) expression were examined. Human chondrocytes were stimulated with interleukin‐ (IL‐) 1β and interfered with vectors altering circMELK, miR‐497‐5p, and MyD88 expression to observe their effects on cell viability, cell cycle and apoptosis, autophagy, and inflammation. The binding relationship between RNAs was verified. The data presented that OA cartilage tissues presented raised circMELK and MYD88 and inhibited miR‐497‐5p expression. IL‐1β suppressed cell viability, prevented cell cycle, and induced apoptosis, autophagy, and inflammation of chondrocytes. Functionally, IL‐1β‐induced changes of chondrocytes could be attenuated by suppressing circMELK or overexpressing miR‐497‐5p. circMELK acted as a sponge of miR‐497‐5p while miR‐497‐5p was a regulator of MYD88. MYD88 restricted the effect of overexpressing miR‐497‐5p on IL‐1β‐stimulated chondrocytes. MYD88 triggered nuclear factor‐kappaB (NF‐κB) pathway activation. Shortly, CircMELK promotes chondrocyte apoptosis and inhibits autophagy in OA by regulating MYD88/NF‐κB signaling axis through miR‐497‐5p. Our study proposes a new molecular mechanism for the development of OA.

10 July 2024 in JOR SPINE
Verified
Journal Article
Open access
TXTao Xu
Tao Xu
GCGuangzi Chen
Guangzi Chen
JLJian Li
Jian Li
YZYingchi Zhang
Yingchi Zhang
Background: Inflammatory cytokines have been reported to be related to intervertebral disc degeneration (IVDD) in several previous studies. However, it remains unclear about the causal relationship between inflammatory cytokines and IVDD. This study employs Mendelian randomization (MR) to analyze the causal link between inflammatory cytokines and the risk of IVDD.Method: We used genetic variants associated with inflammatory cytokines from a meta‐analysis of genome‐wide association study (GWAS) in 8293 Finns as instrumental variables and IVDD data were sourced from the FinnGen consortium. The main analytical approach utilized Inverse‐Variance Weighting (IVW) with random effects to assess the causal relationship. Additionally, complementary methods such as MR‐Egger, weighted median, simple mode, weighted mode, and MR pleiotropy residual sum and outlier were employed to enhance the robustness of the final results.Result: We found interferon‐gamma (IFN‐γ, p = 2.14 × 10–6, OR = 0.870, 95% CI = 0.821–0.921), interleukin‐1 beta (IL‐1b, p = 0.012, OR = 0.951, 95% CI = 0.914–0.989), interleukin‐4 (IL‐4, p = 0.034, OR = 0.946, 95% CI = 0.899–0.996), interleukin‐18 (IL‐18, p = 0.028, OR = 0.964, 95% CI = 0.934–0.996), granulocyte colony‐stimulating factor (GCSF, p = 0.010, OR = 0.919, 95% CI = 0.861–0.980), and Stromal cell‐derived factor 1a (SDF1a, p = 0.014, OR = 1.072, 95% CI = 1.014–1.134) were causally associated with risk of IVDD.Conclusion: Our MR analyses found a potential causal relationship between six inflammation cytokines (IFN‐γ, IL‐1b, IL‐4, IL‐18, SDF1a, and GCSF) and altered IVDD risk.